The Mexican healthcare sector has been through a roller-coaster 2019. Budget cuts have limited public sector maneuverability and uncertainty has made many investors cautious regarding short-term expansion and investment plans. While the hurdles have been significant, the Mexican economy remains steady and the local market for pharmaceuticals and medical devices shows promise. The current administration led by President Andrés Manuel López Obrador positioned universal healthcare at the top of the agenda, along with the need to address the rise in chronic diseases and to counterattack corruption in the system.
